Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedAug 25, 2026
DataAggregated Company Financials
Companies9
- 7D-4.0%
- 3M3.2%
- 1Y-9.3%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 4.0%, driven by declines in Anhui Huaren Health Pharmaceutical and Sichuan Hezong Medicine Easy-to-buy Pharmaceutical of 7.3% and 14%, respectively. Overall the industry is down 9.3% in 12 months. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 25 Aug 2026 | CN¥83.2b | CN¥122.8b | CN¥4.2b | 24.2x | 19.8x | 0.7x |
| Thu, 23 Jul 2026 | CN¥81.0b | CN¥122.8b | CN¥4.2b | 23.5x | 19.3x | 0.7x |
| Sat, 20 Jun 2026 | CN¥75.6b | CN¥122.8b | CN¥4.2b | 22.4x | 18x | 0.6x |
| Mon, 18 May 2026 | CN¥87.6b | CN¥123.1b | CN¥4.2b | 26x | 20.9x | 0.7x |
| Wed, 15 Apr 2026 | CN¥84.9b | CN¥121.3b | CN¥3.6b | 24.5x | 23.7x | 0.7x |
| Fri, 13 Mar 2026 | CN¥92.0b | CN¥121.2b | CN¥3.6b | 25.9x | 25.6x | 0.8x |
| Sun, 08 Feb 2026 | CN¥96.2b | CN¥121.2b | CN¥3.6b | 27.7x | 26.7x | 0.8x |
| Tue, 06 Jan 2026 | CN¥88.7b | CN¥121.2b | CN¥3.6b | 27.1x | 24.7x | 0.7x |
| Thu, 04 Dec 2025 | CN¥90.9b | CN¥121.2b | CN¥3.6b | 29.1x | 25.3x | 0.8x |
| Sat, 01 Nov 2025 | CN¥89.9b | CN¥121.1b | CN¥3.5b | 28.8x | 25.7x | 0.7x |
| Mon, 29 Sep 2025 | CN¥88.2b | CN¥120.6b | CN¥3.3b | 30x | 26.4x | 0.7x |
| Wed, 27 Aug 2025 | CN¥92.0b | CN¥120.5b | CN¥3.2b | 31.6x | 29.1x | 0.8x |
| Fri, 25 Jul 2025 | CN¥92.9b | CN¥120.4b | CN¥3.3b | 32.1x | 28.5x | 0.8x |
| Sun, 22 Jun 2025 | CN¥89.9b | CN¥120.4b | CN¥3.3b | 30x | 27.6x | 0.7x |
| Tue, 20 May 2025 | CN¥94.2b | CN¥120.4b | CN¥3.3b | 30.5x | 28.9x | 0.8x |
| Thu, 17 Apr 2025 | CN¥93.4b | CN¥121.0b | CN¥3.9b | 23.1x | 24.1x | 0.8x |
| Sat, 15 Mar 2025 | CN¥90.3b | CN¥121.0b | CN¥3.9b | 20.4x | 23.1x | 0.7x |
| Mon, 10 Feb 2025 | CN¥82.6b | CN¥121.0b | CN¥3.9b | 18.8x | 21.2x | 0.7x |
| Wed, 08 Jan 2025 | CN¥81.9b | CN¥121.0b | CN¥3.9b | 19.1x | 21x | 0.7x |
| Fri, 06 Dec 2024 | CN¥88.5b | CN¥121.0b | CN¥3.9b | 19.6x | 22.7x | 0.7x |
| Sun, 03 Nov 2024 | CN¥91.6b | CN¥121.0b | CN¥3.9b | 21.1x | 23.5x | 0.8x |
| Tue, 01 Oct 2024 | CN¥90.4b | CN¥119.6b | CN¥4.3b | 20.6x | 20.9x | 0.8x |
| Thu, 29 Aug 2024 | CN¥67.4b | CN¥118.3b | CN¥4.8b | 14.9x | 14.1x | 0.6x |
| Sat, 27 Jul 2024 | CN¥75.4b | CN¥118.4b | CN¥4.8b | 17.1x | 15.7x | 0.6x |
| Mon, 24 Jun 2024 | CN¥93.9b | CN¥118.4b | CN¥4.8b | 22.1x | 19.6x | 0.8x |
| Wed, 22 May 2024 | CN¥127.4b | CN¥118.4b | CN¥4.8b | 26.1x | 26.6x | 1.1x |
| Fri, 19 Apr 2024 | CN¥119.8b | CN¥114.8b | CN¥5.2b | 22.4x | 23x | 1x |
| Sun, 17 Mar 2024 | CN¥118.0b | CN¥115.9b | CN¥5.8b | 19.8x | 20.3x | 1x |
| Tue, 13 Feb 2024 | CN¥122.1b | CN¥115.9b | CN¥5.8b | 20.5x | 21x | 1.1x |
| Thu, 11 Jan 2024 | CN¥128.1b | CN¥116.0b | CN¥5.7b | 22.1x | 22.3x | 1.1x |
| Sat, 09 Dec 2023 | CN¥124.9b | CN¥116.0b | CN¥5.7b | 22.5x | 21.8x | 1.1x |
| Mon, 06 Nov 2023 | CN¥121.3b | CN¥115.4b | CN¥5.7b | 22.1x | 21.3x | 1.1x |
| Wed, 04 Oct 2023 | CN¥120.4b | CN¥113.6b | CN¥5.7b | 23.1x | 21.2x | 1.1x |
| Fri, 01 Sep 2023 | CN¥124.3b | CN¥113.2b | CN¥5.7b | 24.4x | 21.9x | 1.1x |
Price to Earnings Ratio
21.9x
Current Industry PE
- Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 19.8x which is lower than its 3-year average PE of 22.8x.
- The industry is trading close to its 3-year average PS ratio of 0.81x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have declined 9.5% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | -5.02% | |
| Consumer Staples | -0.99% | |
| Food and Staples Retail | -4.72% | |
| Drug Retail | -3.96% | |
| Big Box Super Stores | 0.51% | |
| Food Distributors | -2.05% | |
| Food Retail | -6.19% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603233 DaShenLin Pharmaceutical Group | CN¥18.41 | 2.8% +CN¥569.4m | 7.3% | PE15.4x | |
| 002727 Yixintang Pharmaceutical Group | CN¥11.77 | 0.3% +CN¥23.0m | -23.0% | PE24.2x | |
| 605266 Jianzhijia Pharmaceutical Chain Group | CN¥16.86 | 0.06% +CN¥1.5m | -22.6% | PE16.6x |